Viiv Health Care Apretude

Listing Websites about Viiv Health Care Apretude

Filter Type:

Long-acting PrEP APRETUDE (cabotegravir)

(9 days ago) People also askWho is ViiV Healthcare?About ViiV Healthcare ViiV Healthcare is a global specialist HIV company established in November 2009 by GSK (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in treatment and care for people living with HIV and for people who are at risk of acquiring HIV. Shionogi became a ViiV shareholder in October 2012.ViiV Healthcare’s cabotegravir for HIV prevention receives positive viivhealthcare.comWhat's new at ViiV Healthcare?Kimberly Smith, M.D., MPH, Head of Research & Development at ViiV Healthcare, said: “As leaders in developing long acting injectables for the treatment of HIV, we’re excited to present new data setting the stage for ViiV’s next generation of medicines and demonstrating how key pipeline assets will target HIV in different ways.ViiV Healthcare to present data for its next generation of ultra long viivhealthcare.comDoes ViiV Healthcare recommend a doctor?Inclusion of a physician is not and does not imply a referral, an endorsement, or a recommendation by ViiV Healthcare. Doctors included in this list have not endorsed ViiV Healthcare or any of its products.PrEP Locator APRETUDE (cabotegravir)apretude.comWhat are the ingredients in ViiV Healthcare?Inactive ingredients: mannitol, polyethylene glycol (PEG) 3350, polysorbate 20, and Water for Injection. Manufactured for: ViiV Healthcare Durham, NC 27701 Trademarks are owned by or licensed to the ViiV Healthcare group of companies. ©2023 ViiV Healthcare group of companies or its licensor. APR:3PILHIGHLIGHTS OF PRESCRIBING INFORMATION APRETUDE. - GSKprogskpro.comFeedbackViiV Healthcarehttps://viivhealthcare.com/hiv-news-and-media/news/ViiV Healthcare announces FDA approval of Apretude …WebLondon, 21 December 2021 – ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi Limited as …

https://apretude.com/#:~:text=APRETUDE%20is%20a%20prescription%20medicine%20used%20for%20HIV-1,at%20least%2077%20pounds%20%28at%20least%2035%20kg%29.

Category:  Medicine Show Health

ViiV Healthcare Announces Health Canada Approval for APRETUDE

(5 days ago) WebViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi as shareholders, announced …

https://finance.yahoo.com/news/viiv-healthcare-announces-health-canada-120100247.html

Category:  Health Show Health

ViiV Healthcare : FDA Approves Apretude, Long-acting

(2 days ago) WebViiV Healthcare noted that it will begin shipping Apretude to wholesalers and specialty distributors in the US in early 2022. ViiV Healthcare has initiated …

https://www.nasdaq.com/articles/viiv-healthcare-%3A-fda-approves-apretude-long-acting-injectable-option-for-hiv-prevention

Category:  Health Show Health

ViiV Healthcare Announces Health Canada Approval for …

(6 days ago) WebJean-Francois Fortin, Country Medical Director, Canada at ViiV Healthcare, said: "With the approval of APRETUDE in Canada, we are proud to be able to offer a …

https://www.newswire.ca/news-releases/viiv-healthcare-announces-health-canada-approval-for-apretude-cabotegravir-tablets-and-extended-release-injectable-suspension-for-pre-exposure-prophylaxis-prep-to-reduce-the-risk-of-sexually-acquired-hiv-848877047.html

Category:  Medical Show Health

GlaxoSmithKline’s HIV prevention injectable Apretude threatens …

(7 days ago) WebViiV is offering Apretude at the wholesale acquisition cost of $3,700 per vial, a company spokesperson told Fierce Pharma. Given its bimonthly dosing, Apretude …

https://www.fiercepharma.com/pharma/glaxosmithkline-first-long-acting-hiv-prep-injectable-apretude-fda-approval-threaten-gilead

Category:  Health Show Health

Apretude Approved—the First Long-Acting Injectable …

(8 days ago) WebApretude, which is administered by a health care worker every other month, is indicated for adults and adolescents weighing at least 77 pounds to reduce the risk of …

https://www.poz.com/article/apretude-approvedthe-first-longacting-injectable-prep-option

Category:  Health Show Health

ViiV Healthcare Announces Health Canada Approval for APRETUDE

(8 days ago) WebViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi as shareholders, announced …

https://ca.finance.yahoo.com/news/viiv-healthcare-announces-health-canada-120100181.html

Category:  Health Show Health

Home APRETUDE (cabotegravir 200 mg/mL) HCP Website

(4 days ago) WebDESCOVY and TRUVADA are owned by Gilead Sciences, Inc. All other trademarks are owned by or licensed to the ViiV Healthcare group of companies. This site is funded and …

https://apretudehcp.com/

Category:  Health Show Health

ViiV Healthcare announces US FDA approval of Apretude - GSK

(Just Now) WebViiV Healthcare will begin shipping Apretude to wholesalers and specialty distributors in the US in early 2022. ViiV Healthcare has initiated submissions to other …

https://us.gsk.com/en-us/media/press-releases/viiv-healthcare-announces-us-fda-approval-of-apretude-cabotegravir-extended-release-injectable-suspension-the-first-and-only-long-acting-injectable-option-for-hiv-prevention/

Category:  Health Show Health

Health Canada approves Apretude, the first long-acting injectable …

(5 days ago) WebThe manufacturer of Apretude, ViiV Healthcare, is negotiating with private insurance formularies; the drug should receive coverage from them within two to three …

https://www.catie.ca/catie-news/health-canada-approves-apretude-the-first-long-acting-injectable-for-hiv-prevention

Category:  Health Show Health

APRETUDE Events ViiV Healthcare Programs

(4 days ago) WebFind virtual events for APRETUDE (cabotegravir 200 mg/mL), an injectable PrEP option for individuals (≥35 kg) This site is funded and developed by ViiV Healthcare. This site is …

https://viivprograms.com/apretude/

Category:  Health Show Health

Breakthrough HIV reported in injectable PrEP trial; experts say …

(9 days ago) WebFeb. 15, 2022, 11:22 AM PST / Updated Feb. 16, 2022, 12:30 PM PST. By Benjamin Ryan. In a large clinical trial assessing Apretude, ViiV Healthcare’s recently approved …

https://www.nbcnews.com/nbc-out/out-health-and-wellness/new-injectable-hiv-prevention-drug-fails-seven-people-rcna16298

Category:  Health Show Health

PrEP Locator APRETUDE (cabotegravir)

(4 days ago) WebViiV Healthcare has compiled the list of doctors who have been provided information about APRETUDE by ViiV Healthcare in this directory. Inclusion of a physician is not and does …

https://apretude.com/prep-locator/

Category:  Health Show Health

ViiV Healthcare receives EC approval for Apretude to prevent HIV

(Just Now) WebThe European Commission has approved ViiV Healthcare’s Apretude (cabotegravir long-acting (LA) injectable and tablets) to prevent HIV (human …

https://www.ns-healthcare.com/news/viiv-healthcare-receives-ec-approval-for-apretude-to-prevent-hiv/

Category:  Health Show Health

HIGHLIGHTS OF PRESCRIBING INFORMATION APRETUDE.

(4 days ago) Web• APRETUDE must be administered by a healthcare provider by gluteal intramuscular injection [see Dosage and Administration (2.7)]. • APRETUDE may be initiated with oral …

https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Apretude/pdf/APRETUDE-PI-PIL-IFU.PDF

Category:  Health Show Health

APRETUDE (cabotegravir) Savings

(3 days ago) WebProvide dedicated patient support for your practice. Assess financial assistance programs for commercially insured and uninsured patients*. For more information on accessing …

https://www.viivconnect.com/hcp/get-financial-support/apretude/

Category:  Health Show Health

ViiV Healthcare announces US FDA approval of Apretude - GSK

(1 days ago) WebViiV Healthcare will begin shipping Apretude to wholesalers and specialty distributors in the US in early 2022. ViiV Healthcare has initiated submissions to other …

https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-announces-us-fda-approval-of-apretude-cabotegravir-extended-release-injectable-suspension-the-first-and-only-long-acting-injectable-option-for-hiv-prevention/

Category:  Health Show Health

Apretude 30 mg film-coated tablets - Patient Information Leaflet …

(Just Now) WebThe Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. Last updated on emc: 16 May 2024. This medicinal product is subject to …

https://www.medicines.org.uk/emc/product/15694/pil

Category:  Medicine Show Health

Santé Canada approuve Apretude, premier produit injectable à …

(Just Now) WebLe fabricant d’Apretude, ViiV Healthcare, a entamé des négociations avec des compagnies d’assurances privées dans l’espoir de faire couvrir son médicament …

https://www.catie.ca/fr/nouvelles-catie/sante-canada-approuve-apretude-premier-produit-injectable-a-longue-duree-daction

Category:  Health Show Health

Filter Type: